Sun Pharma gains; unit Taro beats July-September estimates

Sun Pharmaceutical Industries Ltd gained 3.4 per cent today after its unit Taro Pharmaceutical Industries Ltd operational earnings beat some analysts estimates.

Taro's quarterly earnings per share came at $2.15 while sales rose 27.5 per cent to $205.3 million.

Analysts said a price hike in certain product categories by Taro led to the operating earnings beat while also boosting outlook for Sun Pharmaceutical's earnings results later in the day.

Copyright: Thomson Reuters 2013